GCG and type 2 diabetes mellitus: Briefly, in that manuscript, we hypothesized that the new generation beta-blockers, observed clinically as less T2DM-inducing than the old generation, could owe that advantage, at least partially, to the compensating incretin effect enhanced by their off-target interactions with gut hormone receptors.